<p>ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy</p>

Original Research

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy

Total article views		HTML views	PDF downloads	Totals
12,983	Dovepress*	9,990+	1,230	11,220
	PubMed Central*	2,993	986	3,979
	Totals	12,983	2,216	15,199
*Since 14 November 2019

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
28	1	0	0	5	22